These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15123637)

  • 1. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action.
    Liekens S; Hernández AI; Ribatti D; De Clercq E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
    J Biol Chem; 2004 Jul; 279(28):29598-605. PubMed ID: 15123637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
    Liekens S; Bronckaers A; Hernández AI; Priego EM; Casanova E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
    Mol Pharmacol; 2006 Aug; 70(2):501-9. PubMed ID: 16675660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds.
    Liekens S; Balzarini J; Hernández AI; De Clercq E; Priego EM; Camarasa MJ; Pérez-Pérez MJ
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):975-80. PubMed ID: 17065049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.
    Casanova E; Hernandez AI; Priego EM; Liekens S; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    J Med Chem; 2006 Sep; 49(18):5562-70. PubMed ID: 16942029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.
    Liekens S; Bronckaers A; Belleri M; Bugatti A; Sienaert R; Ribatti D; Nico B; Gigante A; Casanova E; Opdenakker G; Pérez-Pérez MJ; Balzarini J; Presta M
    Mol Cancer Ther; 2012 Apr; 11(4):817-29. PubMed ID: 22302099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.
    Pérez-Pérez MJ; Priego EM; Hernández AI; Camarasa MJ; Balzarini J; Liekens S
    Mini Rev Med Chem; 2005 Dec; 5(12):1113-23. PubMed ID: 16375757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59).
    Bronckaers A; Aguado L; Negri A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ; Gago F; Liekens S
    Biochem Pharmacol; 2009 Aug; 78(3):231-40. PubMed ID: 19389384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.
    Balzarini J; Degrève B; Esteban-Gamboa A; Esnouf R; De Clercq E; Engelborghs Y; Camarasa MJ; Pérez-Pérez MJ
    FEBS Lett; 2000 Oct; 483(2-3):181-5. PubMed ID: 11042277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
    Miszczak-Zaborska E; Smolarek M; Bartkowiak J
    Postepy Biochem; 2010; 56(1):61-6. PubMed ID: 20499682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase.
    Balzarini J; Gamboa AE; Esnouf R; Liekens S; Neyts J; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
    FEBS Lett; 1998 Oct; 438(1-2):91-5. PubMed ID: 9821965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 6-substituted uracil analogs as inhibitors of the angiogenic actions of thymidine phosphorylase.
    Klein RS; Lenzi M; Lim TH; Hotchkiss KA; Wilson P; Schwartz EL
    Biochem Pharmacol; 2001 Nov; 62(9):1257-63. PubMed ID: 11705459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cancer progression by inhibition of angiogenesis and induction of apoptosis.
    Liekens S
    Verh K Acad Geneeskd Belg; 2008; 70(3):175-91. PubMed ID: 18669159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of multisubstrate bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylase.
    Allan AL; Gladstone PL; Price ML; Hopkins SA; Juarez JC; Doñate F; Ternansky RJ; Shaw DE; Ganem B; Li Y; Wang W; Ealick S
    J Med Chem; 2006 Dec; 49(26):7807-15. PubMed ID: 17181163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorophosphonylated nucleoside derivatives as new series of thymidine phosphorylase multisubstrate inhibitors.
    Diab SA; De Schutter C; Muzard M; Plantier-Royon R; Pfund E; Lequeux T
    J Med Chem; 2012 Mar; 55(6):2758-68. PubMed ID: 22372816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine phosphorylase from Escherichia coli: tight-binding inhibitors as enzyme active-site titrants.
    Gbaj A; Edwards PN; Reigan P; Freeman S; Jaffar M; Douglas KT
    J Enzyme Inhib Med Chem; 2006 Feb; 21(1):69-73. PubMed ID: 16570508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenic activity of a novel multi-substrate analogue inhibitor of thymidine phosphorylase.
    Liekens S; Bilsen F; De Clercq E; Priego EM; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
    FEBS Lett; 2002 Jan; 510(1-2):83-8. PubMed ID: 11755536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, evaluation of thymidine phosphorylase and angiogenic inhibitory potential of ciprofloxacin analogues: Repositioning of ciprofloxacin from antibiotic to future anticancer drugs.
    Shahzad SA; Sarfraz A; Yar M; Khan ZA; Naqvi SAR; Naz S; Khan NA; Farooq U; Batool R; Ali M
    Bioorg Chem; 2020 Jul; 100():103876. PubMed ID: 32388426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase.
    Esteban-Gamboa A; Balzarini J; Esnouf R; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
    J Med Chem; 2000 Mar; 43(5):971-83. PubMed ID: 10715161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides.
    Fukushima M; Suzuki N; Emura T; Yano S; Kazuno H; Tada Y; Yamada Y; Asao T
    Biochem Pharmacol; 2000 May; 59(10):1227-36. PubMed ID: 10736423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
    Balzarini J; Sienaert R; Liekens S; Van Kuilenburg A; Carangio A; Esnouf R; De Clercq E; McGuigan C
    Mol Pharmacol; 2002 May; 61(5):1140-5. PubMed ID: 11961132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.